These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 18000488)

  • 41. Bipolar disorder, schizoaffective disorder, and schizophrenia overlap: a new comorbidity index.
    Laursen TM; Agerbo E; Pedersen CB
    J Clin Psychiatry; 2009 Oct; 70(10):1432-8. PubMed ID: 19538905
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of schizoaffective disorder - a challenge for evidence-based psychiatry.
    Jäger M; Becker T; Weinmann S; Frasch K
    Acta Psychiatr Scand; 2010 Jan; 121(1):22-32. PubMed ID: 19570108
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Electronic monitoring of antipsychotic medication adherence in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of its reliability and predictive validity.
    Nakonezny PA; Byerly MJ; Rush AJ
    Psychiatry Res; 2008 Jan; 157(1-3):259-63. PubMed ID: 17935793
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Remission in schizophrenia: one-year Italian prospective study of risperidone long-acting injectable (RLAI) in patients with schizophrenia or schizoaffective disorder.
    Rossi A; Bagalà A; Del Curatolo V; Scapati F; Bernareggi MM; Giustra MG;
    Hum Psychopharmacol; 2009 Oct; 24(7):574-83. PubMed ID: 19790173
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Influence of treatment course on the success of psychopharmacotherapy].
    Gaebel W
    Psychiatr Prax; 1985 Jan; 12(1):13-8. PubMed ID: 2858897
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Schizophrenic psychoses with bipolar course--implications for nosology and treatment].
    Jäger M; Lang FU; Frasch K; Becker T
    Fortschr Neurol Psychiatr; 2012 Sep; 80(9):520-6. PubMed ID: 22951771
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Schizoaffective Disorder in the DSM-5.
    Malaspina D; Owen MJ; Heckers S; Tandon R; Bustillo J; Schultz S; Barch DM; Gaebel W; Gur RE; Tsuang M; Van Os J; Carpenter W
    Schizophr Res; 2013 Oct; 150(1):21-5. PubMed ID: 23707642
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk of mental disorders in subjects with intellectual disability in the Lundby cohort 1947-97.
    Nettelbladt P; Göth M; Bogren M; Mattisson C
    Nord J Psychiatry; 2009; 63(4):316-21. PubMed ID: 19229734
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Nosological status of the intermediate area between schizophrenia and affective disorder].
    Abe T; Kato S
    Seishin Shinkeigaku Zasshi; 2006; 108(6):556-70. PubMed ID: 16910533
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Psychopharmacotherapy for addictive and comorbid disorders: current studies.
    Pechter BM; Miller NS
    J Addict Dis; 1997; 16(4):23-40. PubMed ID: 9328807
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Psychopharmacology in the secondary and tertiary prevention of mental illness.
    Ban TA
    Act Nerv Super (Praha); 1977 Jul; 19 Suppl 2():403-8. PubMed ID: 45168
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The psychotic patient and drugs].
    Maillard M; Tholose A; Migayrou JF; Coutanceau R
    Ann Med Psychol (Paris); 1979 Sep; 137(6-7):663-71. PubMed ID: 507612
    [No Abstract]   [Full Text] [Related]  

  • 54. Clinical management of cardiovascular risks during treatment with psychotropic drugs.
    Glassman AH
    J Clin Psychiatry; 2002; 63 Suppl 9():12-7. PubMed ID: 12088171
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The schizophrenia spectrum and other psychotic disorders in the DSM-5].
    Tan N; van Os J
    Tijdschr Psychiatr; 2014; 56(3):167-72. PubMed ID: 24643825
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Beliefs about medications: measurement and relationship to adherence in patients with severe mental disorders.
    Jónsdóttir H; Friis S; Horne R; Pettersen KI; Reikvam A; Andreassen OA
    Acta Psychiatr Scand; 2009 Jan; 119(1):78-84. PubMed ID: 18983630
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combined treatment with amisulpride in patients with schizophrenia discharged from a short-term hospitalization unit: a 1-year retrospective study.
    Molina JD; Lerma-Carrillo I; Leonor M; Pascual F; Blasco-Fontecilla H; González-Parra S; López-Muñoz F; Alamo C
    Clin Neuropharmacol; 2009; 32(1):10-5. PubMed ID: 18978498
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Influence of personality factors on the success of psychopharmacotherapy].
    Rüger U
    Psychiatr Prax; 1985 Jan; 12(1):5-7. PubMed ID: 2858900
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients.
    Fujikawa M; Togo T; Yoshimi A; Fujita J; Nomoto M; Kamijo A; Amagai T; Uchikado H; Katsuse O; Hosojima H; Sakura Y; Furusho R; Suda A; Yamaguchi T; Hori T; Kamada A; Kondo T; Ito M; Odawara T; Hirayasu Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):755-60. PubMed ID: 18226436
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ["Sluggish schizophrenia" (concerning the article by A.B. Smulevich and P.V. Mikhalev (S.S. Korsakov zhurnal nevropatologii i psikhiatrii, No. 12, l987, pp. 186-187].
    Aliev N
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(2):132. PubMed ID: 1355941
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.